Listen now to the second breast cancer podcast which has been launched on the Oncology News website, called

‘Embracing genetic mainstreaming’ with Cath Shannon (medical oncologist, Mater) and Amy Pearn (genetic counsellor)

This is a timely podcast as it is likely the PARPi inhibitor will have a PBS listing in the next couple of months, so patient numbers will be increasing through clinical genetic services.

Listen now: https://oncologynetwork.com.au/episode-2-embracing-genetic-mainstreaming/